A detailed history of Auour Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Auour Investments LLC holds 300 shares of LLY stock, worth $230,328. This represents 0.1% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$230,328
Previous $271,000 2.21%
% of portfolio
0.1%
Previous 0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $177,660 - $237,684
300 New
300 $233,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Auour Investments LLC Portfolio

Follow Auour Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auour Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Auour Investments LLC with notifications on news.